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Sievers Editorial Commentarysomewhat stiffer than virgin young material (such as with a
bioprosthesis or in older patients4).
Assessment of the results of repair by direct visualization
is the commonly used technique not imitating diastolic
pressure. Without diastolic pressure, the leaflets show
unpredictable irregularities in their morphologic appear-
ance, making the assessment difficult (Figure 1, B and C).
The strength of thework of Tsagakis and colleagues1 is their
reintroduction of angioscopy of the aortic valve after
repair.5 This technique nicely shows the morphology of
the leaflets, but only from a top view in 2 dimensions.
The coaptation line can clearly be seen, but less so the
height of the leaflets and the coaptation depth. For assess-
ment of the functional relevance of the abnormalities,
adequate diastolic pressure and simultaneous quantification
of regurgitation would be helpful. Probably the presented
angioscopic visualization will be refined in an attempt to
reach a precision that allows decision making. Aside from
that, the questions are as follows: What is in general the
value of angioscopy, and what is its difference from
commonly used direct inspection of the repaired valve?
Furthermore, can we improve this direct inspection
with special holders imitating diastolic pressure? In the
future, probably other techniques such as preoperative
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The Journal of Thoracic and Carpossibility of in vitro preclinical repair attempts or even
more sophisticated computational evaluation will provide
detailed information on how to repair before we step into
the operating room.
After all, long-term results of more than 20 years in these
relatively young patients are needed to find the best
indications, techniques, and limitations. Prospective,
randomized trials would give the most reliable answers,
but the complexity of pathologies and the diversity of
surgical techniques are considerable obstacles. Meanwhile
we must rely on quorum sensing, and every measure to
improve the quality of repair is desirable. Angioscopy
may become one of those tools.
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Massimo Boffini, MD, and Mauro Rinaldi, MD, Torino, ItalySee related commentary on pages 1672-3.Port-access technology with an endoaortic clamp (EC)
or transthoracic clamp has been widely adopted and
confirmed as having excellent clinical outcomes.1 Never-
theless, concerns still remain about the risks of vascularand neurologic events potentially associated with the use
of retrograde aortic perfusion and balloon manipulation,
particularly in patients with aortoiliac atheromatous
disease.2,3
Because of these concerns, a minimally invasive
approach is denied to these high-risk patients relegating
them to standard sternotomy. This situation prompted the
development of a device for direct ascending aortic cannu-
lation and clamping to extend minimally invasive mitral
valve surgery (MIMVS) even to patients initially ineligible.
The Endodirect (ED) cannula (Edwards Lifesciences, Ir-
vine, Calif) allows antegrade arterial perfusion and inser-
tion of an EC for aortic clamping, cardioplegia delivery,
and aortic venting.4 Potentially, its use can avoid the risk
of aortoiliac dissection and of retrograde embolism with
neurologic injury related to retrograde aortic perfusion. It
also provides a better stability for the EC and a lower risk
of balloon migration.diovascular Surgery c Volume 149, Number 6 1669
TABLE 1. Preoperative patient characteristics, operative details, and
postoperative outcomes (n ¼ 65)
Age (y, mean  SD) 68.7  9.5
Female sex (no.) 14 (21.5%)
Body mass index (kg/m2, mean  SD) 25.0  3.7
Hypertension (no.) 43 (66.1%)
Diabetes (no.) 4 (6.1%)
Chronic obstructive pulmonary disease (no.) 6 (9.2%)
Atrial fibrillation (no.) 19 (29.2%)
Peripheral vascular disease (no.) 40 (61.6%)
Abdominal aortic aneurism (no.) 6 (9.2%)
Aortoiliac-femoral high tortuosity (no.) 19 (29.2%)
Ischemic MR (no.) 14 (21.5%)
Degenerative MR (no.) 37 (56.9%)
Logistic euroSCORE (mean  SD) 9.7  13.1
Ejection fraction (%, mean  SD) 55.9  13.2
PAPs (mm Hg, mean  SD) 45.9  12.7
Previous cardiac surgery (no.) 17 (26.1%)
MV replacement (no.) 12 (18.5%)
Mitral prosthesis replacement (no.) 5 (7.7%)
MV repair (no.) 48 (73.8%)
Combined procedures* (no.) 7 (10.8%)
Atrial fibrillation cryoablation (no.) 9 (13.8%)
Cardiopulmonary bypass duration (mean  SD) 114.4  84.5
Aortic clamp time (mean  SD) 84.5  21.8
Aortic dissection (no.) 0 (0%)
Endoclamp balloon rupture (no.) 1 (1.5%)
Endoclamp balloon rupture migration (no.) 0 (0%)
Conversion to sternotomy (no.) 1 (1.5%)
Ventilation (h, mean  SD) 17.7  29.7
Intensive care unit stay (d, mean  SD) 2.2  2.4
Reoperation for bleeding (no.) 3 (4.6%)
Acute renal failure (no.) 3 (4.6%)
Stroke (no.) 0 (0%)
30-d mortality (no.) 1 (1.5%)
SD, Standard deviation;MR, mitral regurgitation; PAPs, systolic pulmonary artery pres-
sure; MV, mitral valve. *Tricuspid valve repair, atrial septal defect closure, or both.
FIGURE 1. Algorithm for cannulation and clamping strategy. ER, Endoreturn
ing (peripheral cannulation); ED, Endodirect (aortic cannulation and endoaortic
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results in the subgroup of patients undergoing MIMVS in
which ED technique was used.
MATERIALS AND METHODS
Between January 2006 and March 2014, a total of 624 MIMVS proce-
dures were performed at our division. In 65 patients (10.6%), aortic cannu-
lation and clamping were achieved with the ED system (Table 1).
Seventeen patients (26.1%) had previously undergone cardiac surgery.
All patients were screened for adequate vascular access either by angiog-
raphy or by angiographic computed tomographic scan.
Indications for ED use included abdominal aortic and peripheral
arterial disease, high tortuosity of the aortoiliac-femoral axis, and very
small femoral arteries. Absolute contraindications included porcelain
aorta and inability to obtain or maintain single-lung ventilation. Relative
contraindications included significant dilation of the ascending aorta (>42
mm), severe chest deformity, and severe adhesions in reoperative surgery.
The algorithm for cannulation and clamping strategy is summarized in
Figure 1.
The study was approved by the institutional review board.
Operative Technique
The ED technique has been previously described.4,5 The patient is
positioned supine with 45 elevated right chest. An anterolateral
minithoracotomy through the fourth intercostal space (5-7 cm skin
incision) is performed, and a properly designed rib retractor is placed
(Figure 2). A thoracoscopic camera is placed just below the incision, a sixth
intercostal space port is created for pump suction and carbon dioxide insuf-
flation. An additional 11-mm port is obtained in the first intercostal space,
roughly at the midclavicular line, for the aortic cannula insertion. Before
heparinization, 2 purse-string sutures closed with two polytetrafluoroethy-
lene pledgets are sutured on the upper right side of the ascending aorta.
Extreme care should be used in placing the 2 purse-string sutures strictly in-
traparietally to avoid transfixing stitches and aortic hematoma, which could
evolve into aortic tearing at the timeof ligation, because in themajority of the
cases the cannulation site is out of the finger control and reach.Venous return
is obtained percutaneously with a jugular and femoral cannulation. Aortic
cannulation is then obtained with the ED inserted through the previously
described port. The peculiarity of this cannula is the presence of a retractile
blade on its tip, allowing its safe single-punch introduction (Figure 3). The(peripheral cannulation and endoaortic clamping); TT, transthoracic clamp-
clamping). Asterisk indicates an ascending aorta diameter less than 42 mm.
gery c June 2015
FIGURE 2. Patient’s positioning and port and incision placements.
FIGURE 3. Technique of direct aortic cannulation with the Endodirect
system. A, Endodirect 24F cannula. B, Two purse-string sutures closed
with 2 polytetrafluoroethylene pledgets in the ascending aorta. C, Endodir-
ect cannula in the ascending aorta.
Surgical Techniques: Acquired
The Journal of Thoracic and CarEC is inserted into the aortic cannula, placing the balloon just distal to the tip
under transesophageal echo guidance. After cardiopulmonary bypass has
been established, the EC can be inflated until the aorta is occluded. A 6-
mgdose of adenosine is injected into the root, and cardioplegia is started. Af-
ter weaning from cardiopulmonary bypass, the arterial cannula is removed
by tying the purse-string sutures. This is done before the venous cannula’s
removal to ensure rapid blood infusion in case of bleeding from the aortic
cannulation site by inverting the flow of the cardiopulmonary bypass.
RESULTS
Through this approach, all types of isolated or combined
mitral procedures can be performed, as listed in Table 1.
Conversion to sternotomy was necessary in 1 case to repair
a tear in the ascending aorta in a patient with a previous car-
diac surgery in whom the ascending aorta adventitia was
completely peeled off during the cannulation phase.
No cases of stroke were recorded. Three patients under-
went reoperation for bleeding not related to the aortic can-
nulation site.
Thirty-day mortality was 1.5% (death unrelated to aortic
cannulation).
DISCUSSION
There are 2 usual approaches for MIMVS. In the first,
aortic occlusion and cardioplegia delivery are performed
through a peripheral EC; in the second, they are performed
through a transthoracic clamp and a separate line into the
ascending aorta for cardioplegia.
ED cannulation has several advantages relative to the
peripherally based approaches. The chief is antegrade
flow, which is mandatory in cases of severe peripheral arte-
rial disease to prevent arterial injuries, aortic dissection, and
strokes. In our series, none of these complications occurred.
The lack of an additional groin incision avoids wound infec-
tions and seroma. Moreover, the possibility of performing a
single aortic purse-string suture to perform perfusion,
clamping, and cardioplegia delivery and air venting isdiovascular Surgery c Volume 149, Number 6 1671
Surgical Techniques: Acquiredvery attractive. In this respect, extreme care should be taken
to avoid dissecting the adventitia from the aortic surface in
reoperative procedures.
To our knowledge, this is the largest series reporting re-
sults on ED technique showing that ED intervention can
be performed successfully and safely. ED use can complete
the alternative strategies of cannulation and perfusion for
MIMVS, avoiding the limitations and the morbidity of a pe-
ripheral approach. Despite the fact that the production of
this cannula has been suspended for regulatory reasons,
our experience underlines that it is definitely a useful and
safe tool that allows us to extend MIMVS also to this sub-
group of high-risk patients.From the Department of Cardiothoracic Surgery, New York University School of
Medicine, New York, NY.
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Barbero and colleagues1 report their institutional experience
with an alternative aortic cannulation strategy for minimally
invasive mitral valve surgery. The technique uses a specif-
ically designed ascending aortic cannula (EndoDirect; Ed-
wards Lifesciences Corporation, Irvine, Calif) that has a
side limb enabling delivery of a balloon-tip catheter. The
autoincising cannula obturator has a retractable knife tip
that combines the process of puncturing the aortic walland delivering the cannula
through the purse-strings.
The catheter paired with this
cannula permits proximal en-
doballoon occlusion of the
aorta, either delivery of ante-
grade cardioplegia or venting,
and monitoring of root pres-
sure. This is all accomplished
while still allowing distal an-
tegrade aortic flow from the
cannula. In summary, this cannula system eliminates the
need for external aortic crossclamping and placement of a
cardioplegia or vent needle while also decreasing the risk
of morbidity from peripheral cannulation in high-risk
patients.
Although these features may provide minimal additional
benefit for the standard sternotomy approach to the heart,
they are very useful for minimally invasive right chest
approaches for mitral valve operations. As we have become
more sophisticated in identifying those subsets of patients
for whom we should not use retrograde perfusion, this
may become the go-to technique for the minimitral
approach when we desire antegrade perfusion. Barbero
and colleagues present their experience and excellent
results when routinely applying this technique to these
patients.gery c June 2015
